115 related articles for article (PubMed ID: 37183435)
41. Tripeptide IRW initiates differentiation in osteoblasts differentiation via the RUNX2 pathway.
Shang N; Bhullar KS; Hubbard BP; Wu J
Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):1138-1146. PubMed ID: 30980895
[TBL] [Abstract][Full Text] [Related]
42. In vitro and in silico anti-osteoporosis activities and underlying mechanisms of a fructan, ABW90-1, from Achyranthes bidentate.
Li T; Hou X; Huang Y; Wang C; Chen H; Yan C
Carbohydr Polym; 2022 Jan; 276():118730. PubMed ID: 34823766
[TBL] [Abstract][Full Text] [Related]
43. Lactoferrin Promotes Osteogenesis through TGF-β Receptor II Binding in Osteoblasts and Activation of Canonical TGF-β Signaling in MC3T3-E1 Cells and C57BL/6J Mice.
Li Y; Wang J; Ren F; Zhang W; Zhang H; Zhao L; Zhang M; Cui W; Wang X; Guo H
J Nutr; 2018 Aug; 148(8):1285-1292. PubMed ID: 29931165
[TBL] [Abstract][Full Text] [Related]
44. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
45. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
Liu H; Hao W; Wang X; Su H
J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
[TBL] [Abstract][Full Text] [Related]
46. Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis.
Huang X; Li S; Lu W; Xiong L
BMC Endocr Disord; 2022 Jul; 22(1):189. PubMed ID: 35869471
[TBL] [Abstract][Full Text] [Related]
47. Rspo 1 promotes osteoblast differentiation via Wnt signaling pathway.
Sharma AR; Choi BS; Park JM; Lee DH; Lee JE; Kim HS; Yoon JK; Song DK; Nam JS; Lee SS
Indian J Biochem Biophys; 2013 Feb; 50(1):19-25. PubMed ID: 23617070
[TBL] [Abstract][Full Text] [Related]
48. miR‑483‑3p promotes the osteogenesis of human osteoblasts by targeting Dikkopf 2 (DKK2) and the Wnt signaling pathway.
Zhou B; Peng K; Wang G; Chen W; Liu P; Chen F; Kang Y
Int J Mol Med; 2020 Oct; 46(4):1571-1581. PubMed ID: 32945363
[TBL] [Abstract][Full Text] [Related]
49. Eurycoma longifolia as a potential alternative to testosterone for the treatment of osteoporosis: Exploring time-mannered proliferative, differentiative and morphogenic modulation in osteoblasts.
Thu HE; Mohamed IN; Hussain Z; Shuid AN
J Ethnopharmacol; 2017 Jan; 195():143-158. PubMed ID: 27818256
[TBL] [Abstract][Full Text] [Related]
50. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
Kim JL; Park SH; Jeong D; Nam JS; Kang YH
Exp Biol Med (Maywood); 2012 Apr; 237(4):417-28. PubMed ID: 22496431
[TBL] [Abstract][Full Text] [Related]
51. MGF-19E peptide promoted proliferation, differentiation and mineralization of MC3T3-E1 cell and promoted bone defect healing.
Wei W; Liu S; Song J; Feng T; Yang R; Cheng Y; Li H; Hao L
Gene; 2020 Jul; 749():144703. PubMed ID: 32339623
[TBL] [Abstract][Full Text] [Related]
52. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
53. Activation of farnesoid X receptor signaling by geniposidic acid promotes osteogenesis.
Liu M; Jin F; Zhang S; Li S; Zhu D; Cui Y; Cai M; Liu X; Zhang Y; Sun Y; Liu C; Wang X
Phytomedicine; 2022 Aug; 103():154258. PubMed ID: 35716540
[TBL] [Abstract][Full Text] [Related]
54. ANKRD1 activates the Wnt signaling pathway by modulating CAV3 expression and thus promotes BMSC osteogenic differentiation and bone formation in ovariectomized mice.
Zhang Y; Zhou L; Fu Q; Liu Z
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166693. PubMed ID: 36958710
[TBL] [Abstract][Full Text] [Related]
55. Sambucus williamsii Hance maintains bone homeostasis in hyperglycemia-induced osteopenia by reversing oxidative stress via cGMP/PKG signal transduction.
Shen YW; Cheng YA; Li Y; Li Z; Yang BY; Li X
Phytomedicine; 2023 Feb; 110():154607. PubMed ID: 36610352
[TBL] [Abstract][Full Text] [Related]
56. Robo2 promotes osteoblast differentiation and mineralization through autophagy and is activated by parathyroid hormone induction.
Yuan N; Wang X; He M
Ann Anat; 2023 Jun; 248():152070. PubMed ID: 36801365
[TBL] [Abstract][Full Text] [Related]
57. ONO-1301 Enhances in vitro Osteoblast Differentiation and in vivo Bone Formation Induced by Bone Morphogenetic Protein.
Kanayama S; Kaito T; Kitaguchi K; Ishiguro H; Hashimoto K; Chijimatsu R; Otsuru S; Takenaka S; Makino T; Sakai Y; Myoui A; Yoshikawa H
Spine (Phila Pa 1976); 2018 Jun; 43(11):E616-E624. PubMed ID: 29016438
[TBL] [Abstract][Full Text] [Related]
58. MiR-655-3p inhibits the progression of osteoporosis by targeting LSD1 and activating BMP-2/Smad signaling pathway.
Wang XJ; Liu JW; Liu J
Hum Exp Toxicol; 2020 Oct; 39(10):1390-1404. PubMed ID: 32431171
[TBL] [Abstract][Full Text] [Related]
59. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
60. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
